Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC39H57N3O5 |
InChIKeyJZDJKWCLKGBXIC-LRVDEVEJSA-N |
CAS Registry2938227-14-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | RU | 01 Mar 2020 |